Literature DB >> 19207586

Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study.

Prodromos Hytiroglou1, Julio A Gutierrez, Maria Freni, Joseph A Odin, Carmen M Stanca, Sukma Merati, Thomas D Schiano, Andrea D Branch, Swan N Thung.   

Abstract

AIM: This long-term study aimed to evaluate recurrence and evolution of primary biliary cirrhosis (PBC) after orthotopic liver transplantation (OLT).
METHODS: We reviewed "blindly" allograft biopsy specimens of women who underwent transplantation for PBC (n = 84), and women who received a transplant for chronic hepatitis C virus infection (CHCV ) (n = 108). All needle liver biopsy specimens obtained more than 6 months post-OLT were examined, including 83 specimens from 44 PBC patients and 152 specimens from 58 CHCV patients.
RESULTS: Granulomatous destructive cholangitis was found in five biopsies from four PBC patients (P = 0.0048). Non-necrotizing epithelioid cell granulomas were present in four biopsies from four PBC patients, and in two biopsies from one CHCV patient. Piecemeal necrosis (P = 0.0002), lobular necroinflammatory activity (P < 0.0001), steatosis (P < 0.0001) and fibrosis (P < 0.0001) were more prevalent in CHCV patients than PBC patients. Four PBC patients developed histologic evidence of autoimmune hepatitis (AIH), at a mean time of 3.66 years post-OLT. One of these patients had histologic features of AIH/PBC overlap syndrome. All four patients developed bridging fibrosis (n = 2) or cirrhosis (n = 2). No other PBC patient had evidence of cirrhosis after OLT.
CONCLUSIONS: Histologic findings indicative of recurrent PBC were present in 15.9% of the PBC patients undergoing biopsy in this series. However, this group of patients did not suffer significant bile duct loss or fibrosis, as compared to the control group, suggesting that recurrent PBC is a mild or slowly progressive disease. Histologic evidence of AIH was observed in allograft biopsies of some PBC patients.

Entities:  

Year:  2009        PMID: 19207586      PMCID: PMC3127546          DOI: 10.1111/j.1872-034X.2008.00483.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  27 in total

Review 1.  Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence.

Authors:  James Neuberger
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

Review 2.  Liver biopsy interpretation for causes of late liver allograft dysfunction.

Authors:  Anthony J Demetris; Oyedele Adeyi; Chris O C Bellamy; Andrew Clouston; Frederic Charlotte; Albert Czaja; Ierachmiel Daskal; Magda S El-Monayeri; Paulo Fontes; John Fung; Bruno Gridelli; Maria Guido; Hironori Haga; John Hart; Eva Honsova; Stefan Hubscher; Tomoo Itoh; Nirag Jhala; Patricia Jungmann; Urmila Khettry; Charles Lassman; Saverio Ligato; John G Lunz; Amadeo Marcos; Marta Ida Minervini; Johan Mölne; Mike Nalesnik; Imad Nasser; Desley Neil; Erin Ochoa; Orit Pappo; Parmjeet Randhawa; Finn P Reinholt; Phil Ruiz; Mylène Sebagh; Marco Spada; Aurelio Sonzogni; Athanassios C Tsamandas; Annika Wernerson; Tong Wu; Funda Yilmaz
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.

Authors:  J Van de Water; L B Gerson; L D Ferrell; J R Lake; R L Coppel; K P Batts; R H Wiesner; M E Gershwin
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

4.  Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.

Authors:  D E Jones; O F James; B Portmann; A D Burt; R Williams; M Hudson
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

5.  Recurrence of primary biliary cirrhosis after transplantation. The pathologist's view.

Authors:  B C Portmann
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-06       Impact factor: 2.566

6.  Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.

Authors:  Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A Talwalkar; Felicity T Enders; Keith D Lindor; Ruud A F Krom; Russell H Wiesner
Journal:  Liver Transpl       Date:  2007-09       Impact factor: 5.799

7.  Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation.

Authors:  S G Hubscher; E Elias; J A Buckels; A D Mayer; P McMaster; J M Neuberger
Journal:  J Hepatol       Date:  1993-06       Impact factor: 25.083

8.  Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.

Authors:  Anurag Maheshwari; Hwan Y Yoo; Paul J Thuluvath
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

9.  Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation.

Authors:  V Balan; K P Batts; M K Porayko; R A Krom; J Ludwig; R H Wiesner
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425

10.  Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis.

Authors:  Etsuko Hashimoto; Makiko Taniai; Satoru Yatsuji; Katsutoshi Tokushige; Keiko Shiratori; Masakazu Yamamoto; Syouhei Fuchinoue
Journal:  Hepatol Res       Date:  2007-10       Impact factor: 4.288

View more
  3 in total

Review 1.  Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

Review 2.  Overlap syndromes: an emerging diagnostic and therapeutic challenge.

Authors:  Pooja Dhiman; Sharad Malhotra
Journal:  Saudi J Gastroenterol       Date:  2014 Nov-Dec       Impact factor: 2.485

Review 3.  Current understanding of primary biliary cholangitis.

Authors:  Atsushi Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.